|
KCTD18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.868200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.864500E-02 |
| Normal-vs-Stage2 |
7.000800E-01 |
| Normal-vs-Stage3 |
1.935200E-01 |
| Normal-vs-Stage4 |
5.237800E-02 |
| Stage1-vs-Stage2 |
5.731600E-01 |
| Stage1-vs-Stage3 |
8.775600E-03 |
| Stage1-vs-Stage4 |
9.968100E-04 |
| Stage2-vs-Stage3 |
2.301600E-01 |
| Stage2-vs-Stage4 |
9.316200E-02 |
| Stage3-vs-Stage4 |
6.122200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.522600E-01 |
| Normal-vs-AfricanAmerican |
6.568200E-01 |
| Normal-vs-Asian |
3.080000E-01 |
| Caucasian-vs-AfricanAmerican |
6.445000E-01 |
| Caucasian-vs-Asian |
3.292400E-01 |
| AfricanAmerican-vs-Asian |
2.292800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.249800E-01 |
| Normal-vs-Female |
1.708800E-01 |
| Male-vs-Female |
4.744400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.346400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.902600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.871000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.809000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.889700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.555500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.369000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.878200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.647400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.187800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.184800E-03 |
| Normal-vs-Grade 2 |
5.607700E-02 |
| Normal-vs-Grade 3 |
7.854800E-01 |
| Normal-vs-Grade 4 |
1.437140E-03 |
| Grade 1-vs-Grade 2 |
1.615590E-01 |
| Grade 1-vs-Grade 3 |
7.115700E-02 |
| Grade 1-vs-Grade 4 |
1.551560E-04 |
| Grade 2-vs-Grade 3 |
3.365900E-02 |
| Grade 2-vs-Grade 4 |
1.76022999999192E-05 |
| Grade 3-vs-Grade 4 |
1.802830E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.41649999999094E-05 |
| Normal-vs-ccB subtype |
7.660900E-03 |
| ccA subtype-vs-ccB subtype |
3.37029959496249E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.136000E-01 |
| Normal-vs-N1 |
2.688400E-01 |
| N0-vs-N1 |
2.276600E-01 |
|
|
